Galectin Therapeutics Q2 FY26 net loss widens 21.17% to $9.11 millionPUBT·Aug 14 at 11:52 AMGALT-2.68%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Aug 4 at 12:05 PMGALT-2.68%ENSC+0.84%
Galectin chair Uihlein receives 34,376,167 shares in debt-to-equity conversionPUBT·Aug 4 at 11:50 AMGALT-2.68%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 14 at 05:05 PMGALT-2.68%CARL-1.99%
U.S. stock market midday update: Galectin Therap up 16.74%, active funds but no news catalystPrice Alert·Jul 14 at 03:53 PMGALT-2.68%
Galectin Therapeutics posts corporate presentation highlighting belapectin program for MASH cirrhosis, portal hypertensionPUBT·Jul 14 at 01:53 PMGALT-2.68%
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focusrttnews·Jul 14 at 02:35 AMAGEN+0.62%SI-0.68%
Galectin Therapeutics CMO Jamil Khurram disposes of common shares worth $262,943PUBT·Jun 30 at 11:23 PMGALT-2.68%
Top 3 Health Care Stocks That May Keep You Up At Night In Junebenzinga_article·Jun 30 at 12:55 PMGALT-2.68%DFTX-1.38%
Galectin Therapeutics CMO Jamil Khurram disposes of 7,557 common shares worth $23,728.98PUBT·Jun 25 at 08:07 PMGALT-2.68%
